SPRAX | VMVAX | SPRAX / VMVAX | |
Total Expense Ratio | 1.13 | 0.07 | 1,614% |
Annual Report Gross Expense Ratio | 1.32 | 0.07 | 1,886% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | 7.796 | 6.339 | 123% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 162M | 32.5B | 0% |
Annual Yield % from dividends | 1.32 | 2.17 | 61% |
Returns for 1 year | 4.16 | 1.20 | 345% |
Returns for 3 years | 38.49 | 36.10 | 107% |
Returns for 5 years | 92.04 | 63.10 | 146% |
Returns for 10 years | 47.33 | 99.51 | 48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSTQX | 14.01 | 0.08 | +0.57% |
Morningstar US Equity | |||
DEQCX | 15.64 | 0.05 | +0.32% |
BNY Mellon Global Equity Income - C | |||
GIGRX | 25.27 | 0.07 | +0.28% |
Gabelli International Growth AAA | |||
FIGCX | 21.94 | N/A | N/A |
Fidelity Advisor International Growth C | |||
MDSPX | 28.68 | -0.10 | -0.35% |
BlackRock Advantage SMID Cap Inv A |